Making It Count: Team CRI Adds On Miles for Cancer Research November 5, 2015December 14, 2022 Jasmine Lingard
FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz
FDA Approves First in a New Class of Immunotherapies October 27, 2015December 14, 2022 Matthew Tontonoz
What Is an Oncogene? Immunologists Rethink a Fundamental Cancer Concept October 21, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
